Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Characterization of a novel cGMP binding protein from rat lung.

× No keyword cloud information.

19 in total

1. Direct allosteric regulation between the GAF domain and catalytic domain of photoreceptor phosphodiesterase PDE6.

Authors: Xiu-Jun Zhang; Karyn B Cahill; Arye Elfenbein; Vadim Y Arshavsky; Rick H Cote
Journal: J Biol Chem Date: 2008-09-08 Impact factor: 5.157

2. Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.

Authors: Jackie D Corbin; Roya Zoraghi; Sharron H Francis
Journal: Cell Signal Date: 2009-08-06 Impact factor: 4.315

3. Identification of a noncatalytic cGMP-binding domain conserved in both the cGMP-stimulated and photoreceptor cyclic nucleotide phosphodiesterases.

Authors: H Charbonneau; R K Prusti; H LeTrong; W K Sonnenburg; P J Mullaney; K A Walsh; J A Beavo
Journal: Proc Natl Acad Sci U S A Date: 1990-01 Impact factor: 11.205

4. The unexpected evolution of basic science studies about cyclic nucleotide action into a treatment for erectile dysfunction.

Authors: Jackie Corbin
Journal: J Biol Chem Date: 2014-12-11 Impact factor: 5.157

5. Cyclic guanosine 3',5'-monophosphate regulates the calcium current in single cells from frog ventricle.

Authors: R Fischmeister; H C Hartzell
Journal: J Physiol Date: 1987-06 Impact factor: 5.182

Review 6. Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.

Authors: Sevil Korkmaz-Icöz; Tamás Radovits; Gábor Szabó
Journal: Br J Pharmacol Date: 2017-03-23 Impact factor: 8.739

7. Characterization of a novel cAMP-binding, cAMP-specific cyclic nucleotide phosphodiesterase (TcrPDEB1) from Trypanosoma cruzi.

Authors: Rocío Díaz-Benjumea; Sunil Laxman; Thomas R Hinds; Joseph A Beavo; Ana Rascón
Journal: Biochem J Date: 2006-10-15 Impact factor: 3.857

8. Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.

Authors: Rakesh C Kukreja; Fadi N Salloum; Anindita Das; Saisudha Koka; Ramzi A Ockaili; Lei Xi
Journal: Exp Clin Cardiol Date: 2011

9. Reciprocal effects of an inhibitory factor on catalytic activity and noncatalytic cGMP binding sites of rod phosphodiesterase.

Authors: A Yamazaki; F Bartucca; A Ting; M W Bitensky
Journal: Proc Natl Acad Sci U S A Date: 1982-06 Impact factor: 11.205

Review 10. ABCD of the phosphodiesterase family: interaction and differential activity in COPD.

Authors: David M G Halpin
Journal: Int J Chron Obstruct Pulmon Dis Date: 2008